Counterfeit photo
YEARS
With increased government support for drug development in India, 16 'blockbusters' for multiple therapeutic areas, including cancer, diabetes, HIV and tuberculosis, are on the way, Department of Pharma Secretary Arunish Chawla told reporters on the sidelines of the CII Pharma and Life Sciences Summit here. Molecule's production in India is being planned.
New Delhi. Despite the slowdown in the global economy, India's pharmaceutical and medical technology exports are expected to continue to grow in the current financial year. A senior government official said this. With increased government support for drug development in India, 16 'blockbusters' for multiple therapeutic areas, including cancer, diabetes, HIV and tuberculosis, are on the way, Department of Pharma Secretary Arunish Chawla told reporters on the sidelines of the CII Pharma and Life Sciences Summit here. Molecule's production in India is being planned.
“We are analyzing export trends in recent data,” he said. Even though there is a general slowdown in exports globally, the good news is that there has been double digit growth in Indian pharmaceutical, biotechnology and bulk drug exports compared to last year. Said this in response to a question asked about the export possibilities of. He further said that the export of these products has now become the fourth largest export of goods for the Indian economy in the first four months of this year. He said that this is a huge achievement and an important milestone. Chawla said the pharmaceutical and medical technology industry is expected to perform strongly going forward.
Disclaimer: Prabhasakshi has not edited this news. This news has been published from PTI-language feed.
other news
